tadalafil has been researched along with Cognitive Dysfunction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, YH; Huang, XF; Ke, HM; Song, GQ; Wang, JH; Xu, DF | 1 |
| Barrick, TR; Benjamin, P; Betteridge, S; Binnie, LR; Clarke, B; Dhillon, MK; Ghatala, R; Hainsworth, AH; Hainsworth, FAH; Howe, FA; Isaacs, JD; Khan, U; Kruuse, C; Madigan, JB; Moynihan, B; Patel, B; Pauls, MMH; Pereira, AC; Rostrup, E; Shtaya, ABY; Spilling, CA; Trippier, S; Williams, R; Young, R | 1 |
| Otari, KV; Patil, RJ; Upasani, CD | 1 |
| Gong, Q; Li, J; Li, X; Ling, D; Mao, F; Ni, W; Wang, H; Wang, M; Zhang, H; Zhang, J; Zheng, X | 1 |
1 trial(s) available for tadalafil and Cognitive Dysfunction
| Article | Year |
|---|---|
The PASTIS trial: Testing tadalafil for possible use in vascular cognitive impairment.
Topics: Aged; Cognitive Dysfunction; Double-Blind Method; Humans; Tadalafil | 2022 |
3 other study(ies) available for tadalafil and Cognitive Dysfunction
| Article | Year |
|---|---|
Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cholinergic Antagonists; Cognitive Dysfunction; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Indole Alkaloids; Mice; Models, Molecular; Molecular Structure; Morris Water Maze Test; Phosphodiesterase 5 Inhibitors; Protein Conformation; Quinazolines; Scopolamine | 2020 |
Improvement of cognitive dysfunction by a novel phosphodiesterase type 5 inhibitor, Tadalafil.
Topics: Cognitive Dysfunction; Cyclic GMP; Humans; Memory Disorders; NG-Nitroarginine Methyl Ester; Phosphodiesterase 5 Inhibitors; Scopolamine; Tadalafil | 2023 |
Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5).
Topics: Acetylcholinesterase; Animals; Brain; Cholinesterase Inhibitors; Cognitive Dysfunction; Cyclic Nucleotide Phosphodiesterases, Type 5; Disease Models, Animal; Mice, Inbred ICR; Molecular Structure; Phosphodiesterase 5 Inhibitors; Random Allocation; Scopolamine; Tadalafil | 2018 |